Cannabis Education in North America: From Chemistry Degrees to Clinical and Commercial Training
Unlock your path in North America's evolving cannabis education—from degrees in chemistry and medicine to policy, business, and lab training.
Articles
CBD Reduced MS-Like Inflammation in Mice by Activating Immune-Suppressing Cells
Could CBD ease MS-like inflammation? A mouse study hints at immune pathways that curb inflammatory T cells suggesting new avenues—clinical trials needed.
Cannabis Is Not an Evidence-Based Substitute for Adderall in ADHD
Cannabis is not an evidence-based substitute for Adderall in ADHD. Learn why it may not improve attention and explore safer, proven treatment options.
CBD Tampons Show Early Potential for Period Pain
Early signals from a small 2023 study suggest CBD-infused tampons may ease period cramps, but proving safety and effectiveness awaits larger trials.
Cannabinoids Help Hemp Resist Chewing Insects, Study Finds
A Cornell AgriTech study hints cannabinoids help hemp resist chewing insects, guiding breeding toward pest-resistant varieties - not a ready-to-use pesticide.
CBD and PEA Reduced Gut-Barrier Disruption in a Small Human Study
Could CBD and PEA protect the gut barrier? A small human study shows reduced permeability with CBD/PEA; hinting at potential—but not a treatment—read more.
NYC Overdose Prevention Centers Were Not Linked to Higher Crime in Initial Study
Could NYC's overdose-prevention centers coexist with safer streets? Early data examine crime links, enforcement shifts, and harm-reduction policy.
Cannabinoids Show Early Promise in Duchenne Muscular Dystrophy
Cannabinoids show early promise for Duchenne muscular dystrophy (DMD) in lab and animal studies, but human benefits remain unproven
Cannabis Strain Names Often Outrun the Genetics Behind Them
A 2019 study finds cannabis strain names often don't align with genetics, making Sativa/Indica labels unreliable and highlighting risks of mislabeling.
Small Australian Trial Finds Little Short-Term Cognitive Change After Prescribed Medical Cannabis
Small Australian trial finds minimal short-term cognitive impact from prescribed medical cannabis, but results aren't universal - more research is needed.